University hospital of grenoble
Grenoble, 38043, France
NCT Number: NCT01457963
The primary objective of this study was to estimate the prevalence of PE among consecutive ICU patients receiving MV who required thoracic computed tomography (CT) with contrast agent injection, regardless of whether PE was suspected clinically. The secondary objectives were to assess the association between PE and DVT, to identify risk factors for VTE, and to determine the outcome of VTE.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Grenoble, 38043, France
Background: Pulmonary embolism (PE) produces nonspecific or minimal symptoms in mechanically ventilated (MV) patients, leading to underdiagnosis. We estimated the prevalence of PE and associations with deep vein thrombosis (DVT) among MV patients.
Methods: Consecutive MV patients who required thoracic computed tomography (CT) in a single ICU. Compression ultrasound of the four limbs was performed within 48 hours of inclusion. Curative anticoagulation therapy was given immediately after PE diagnosis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: CT scan at the day of inclusion
TO estimate the prevalence of PE among consecutive ICU patients receiving MV who required thoracic computed tomography (CT) with contrast agent injection, regardless of whether PE was suspected clinically.
Time frame: CUS within 48 hours after the CT scan
University Hospital, Grenoble
Other
Pulmonary Embolism in Mechanically Ventilated Patients Requiring Computed Tomography: Prevalence, Risk Factors and Outcome
Acronym: PEICU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01828697
Cardiovascular Diseases, Deep Venous Thrombosis
New York, United States
View Trial DetailsNCT04414332
Cardiovascular Diseases, Deep Venous Thrombosis
View Trial DetailsNCT02402881
Cardiovascular Diseases, Deep Venous Thrombosis
Baltimore, Maryland, United States
View Trial DetailsNCT00894283
Cardiovascular Diseases, Deep Venous Thrombosis
Baltimore, Maryland, United States
View Trial Details